Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs

N. Colclough,P.G. Ballard, P. Barton, K. Chen,D.A.E. Cross, M.R.V. Finlay, L. Han,A. Janefeldt,P. Johnström,R.A. Ward,G.L. Wrigley, Y. Yan,J.W.T. Yates, D. Zhang, Z. Zhang

European Journal of Cancer(2016)

引用 17|浏览21
暂无评分
关键词
blood brain barrier,osimertinib,permeability
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要